Although in recent years Ozempic has been often prescribed off-label for weight loss, it is not currently approved for this indication
The most common side effects include nausea, vomiting, diarrhoea, and stomach pain
Always consult a qualified licensed healthcare professional before starting, stopping, or changing any prescription treatment, including any GLP-1 medication
Back Edwards, K, Li, X, Linvay, I (1 April 2023) 'Clinical and safety outcomes with GLP-1 receptor agonists and SGLT2 inhibitors in type 1 diabetes: A real-world study', The Journal of Clinical Endocrinology & Metabolism , 108/ 4, 92030
Patients should not attempt to obtain or use this medication outside of a regulated clinical trial setting